Exiqon

Exiqon was a leading provider of high-performance solutions for RNA analysis, specializing in the development and commercialization of Locked Nucleic Acid (LNA) technology. The company's products included tools for microRNA (miRNA) discovery, profiling, and functional analysis, as well as diagnostic tests for personalized medicine. By leveraging the high affinity and specificity of LNA, Exiqon enabled researchers to achieve superior results in RNA detection and quantification. The company offered a comprehensive portfolio of miRCURY LNA products, including PCR assays, arrays, and in situ hybridization probes. In 2016, Exiqon was acquired by QIAGEN, which integrated its LNA-based portfolio into its molecular diagnostics and life science offerings.